Konrad Hoetzenecker

Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo.

M. Grusch, K. Schelch, P. Heffeter, 2023, Cancer letters.

C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer

K. Schelch, T. Klikovits, V. Laszlo, 2024, World Journal of Surgical Oncology.

LA-ICP-MS analysis reveals differences in chemotherapeutic drug distribution in surgically resected pleural mesothelioma

K. Schelch, T. Klikovits, V. Laszlo, 2023 .